Author

B. Lamont

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

B. M. Russell· 2 shared M.-R. Muhsin-Sharafaldine· 2 shared R. Suwanarusk· 2 shared A. Barron· 1 shared D. Pletzer· 1 shared D. Yung· 1 shared J. E. Nielsen· 1 shared K. Sorensen· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. M. Russell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antiparasitic effect of peptoids against Cryptosporidium parvum

B. Lamont, B. M. Russell, R. Suwanarusk, J. E. Nielsen, K. Sorensen, D. Yung, A. Barron, D. Pletzer, M.-R. Muhsin-Sharafaldine

This study identifies two peptoids, TM9 and TM19, with potent anti-Cryptosporidium parvum activity that does not harm host cells, suggesting their potential as new therapeutics for cryptosporidiosis.

bioRxiv · Jul 16, 2024 · PreprintMicrobiology

Comparative efficacy and safety of anti-cryptosporidial agents: An in vitro study on Nitazoxanide, HFL, KDU731, and Paromomycin against Cryptosporidium parvum

S. Whitta, B. Lamont, R. Suwanarusk, B. M. Russell, M.-R. Muhsin-Sharafaldine

This study compares the in vitro efficacy and safety of four anti-cryptosporidial agents against Cryptosporidium parvum using host cells and molecular assays.

bioRxiv · Feb 9, 2024 · PreprintMicrobiology